You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antiviral

Showing 1 - 25 of 3,604
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

Enrolling by invitation
  • Multiple Sclerosis
  • Truvada (tenofovir/emtricitabine)
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 14, 2023

Passage of Antiviral Antibodies From Mother to Child

Not yet recruiting
  • Pregnant Woman
  • Adult Patient
  • Blood sample and data collection
  • (no location specified)
Apr 24, 2023

Clinical Trials of Investigational or Licensed Vaccines or

Recruiting
  • Vaccines
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Respiratory Syncytial Virus (RSV) Trial in London (RV299, Placebo)

    Completed
    • Respiratory Syncytial Virus (RSV)
    • London, United Kingdom
      Pfizer
    Oct 5, 2023

    Chronic Hepatitis B Trial in Seoul (Standard of care)

    Active, not recruiting
    • Chronic Hepatitis B
    • Standard of care
    • Seoul, Korea, Republic of
    • +3 more
    Mar 29, 2023

    Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

    Recruiting
    • Chronic HBV Infection
    • Peginterferon alfa-2b combined and ETV
    • Shenzhen, China
      Shenzhen Third People Hospital
    Mar 19, 2023

    Real World COVID-19 Antiviral Effectiveness Research

    Not yet recruiting
    • COVID-19
    • Oral Antiviral
    • (no location specified)
    Dec 4, 2022

    Periodontitis Chronic Generalized Severe Trial in Nice, Marseille, Rennes (Antiviral treatment with conventional non-surgical

    Not yet recruiting
    • Periodontitis Chronic Generalized Severe
    • Antiviral treatment with conventional non-surgical treatment
    • Placebo with conventional non-surgical treatment
    • Nice, Alpes Maritimes, France
    • +2 more
    Jun 5, 2023

    CMV Antiviral T-cell Immunity Over Next Six Months Initiation of

    Not yet recruiting
    • Kidney Transplant Infection
    • (no location specified)
    Jan 23, 2023

    Nirmatrelvir-ritonavir in Hospitalized Patients

    Recruiting
    • Hospitalized Patients
    • Hangzhou, Zhejiang, China
      Changcheng Shi
    Feb 26, 2023

    Metabolic Syndrome on Antiviral Response in People With Chronic

    Not yet recruiting
    • Chronic Hepatitis b
      • (no location specified)
      Jan 21, 2023

      Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

      Not yet recruiting
      • Hepatitis B, Chronic
      • Exposure factors
      • (no location specified)
      Sep 10, 2023

      Influenza, Influenza, Human Trial in Bangkok (Drug: Oseltamivir, Drug: Favipiravir, Drug: Zanamivir)

      Not yet recruiting
      • Influenza
      • Influenza, Human
      • Drug: Oseltamivir
      • +6 more
      • Bangkok, Thailand
        Faculty of Tropical Medicine, Mahidol University
      Jan 30, 2023

      Nutrition, Healthy Trial (fish oil)

      Not yet recruiting
      • Nutrition, Healthy
      • fish oil
      • (no location specified)
      Aug 12, 2022

      COVID-19 Infection and Its Clinical Prognosis in Chronic

      Recruiting
      • Chronic Hepatitis B
      • COVID-19 Infection
      • Beijing, Beijing, China
        Department of Hepatology Division 2, Beijing Ditan Hospital
      Mar 28, 2023

      Gastric Cancer Trial in Seoul (Antiviral treatment in combination with low-dose gemcitabine)

      Not yet recruiting
      • Gastric Cancer
      • Antiviral treatment in combination with low-dose gemcitabine
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 21, 2022

      Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

      Recruiting
      • Diabetes Mellitus
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 27, 2023

      Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

      Active, not recruiting
      • Chronic Hepatitis B
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      Apr 20, 2023

      COVID-19, Immunodeficiency Trial (Paxlovid 5 days, Paxlovid 10 days, Tixagevimab and Cilgavimab)

      Not yet recruiting
      • COVID-19
      • Immunodeficiency
      • Paxlovid 5 days
      • +2 more
      • (no location specified)
      Oct 18, 2022

      Antiviral Therapy for Patients With Liver Cancer After Surgery

      Recruiting
      • Hepatocellular Carcinoma
        • Changsha, Hunan, China
          Xiangya Hospital of Central South University
        Jul 19, 2022

        Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)

        Active, not recruiting
        • Covid19
        • Omalizumab
        • Placebo
        • Niagara, Ontario, Canada
        • +2 more
        Nov 14, 2022

        Early Antiviral Responses to Rhinovirus Infection in Asthma

        Not yet recruiting
        • Asthma
        • Rhinovirus infection
        • (no location specified)
        Mar 29, 2022

        Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

        Active, not recruiting
        • Chronic Hepatitis B and Hepatitis D Co-infection
        • HH-003 20mg/kg
        • HH-003 3mg/kg
        • Changchun, Jilin, China
          First Hospital of Jilin University
        Dec 30, 2022

        Antiviral Drugs on the Treatment of SARS-CoV-2

        Recruiting
        • Complication of Medical Care
        • Pneumonia, Viral
        • Nur-Sultan, Kazakhstan
        • +1 more
        Jul 19, 2022

        Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

        Not yet recruiting
        • Liver Cancer
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 9, 2023